Skip to main content
REFRAMING MS
“Advocating for myself has been so important. It’s helped me find the treatment that fits into my life.” – Jamie-Lynn Sigler Actor, MS Advocate, taking KESIMPTA®
Thumbnail image of Jamie-Lynn’s 3-step Guide

Reflect. Reframe. Reach Out. Get the guide.

This 3-step guide can help you define and voice your needs.

 

From Staying Quiet to Speaking Up


I kept my relapsing MS hidden for years for a lot of reasons—and it robbed me of the support I really needed. When I finally had the courage to open up about it, I learned how important it is to advocate for yourself—including talking to your MS specialist—so you can come to a treatment decision together.

Why KESIMPTA Is the Right Fit For Me


As a mom, wife, and actor, I'm pulled in a lot of directions. So I need a treatment that fits with my lifestyle. When my doctor showed me the KESIMPTA trial resultsand safety profile,* I was impressed. And taking KESIMPTA once a month at home really works for me. I love that I can do it at home or on the go.

 
Thumbnail image of Jamie-Lynn Sigler’s cover page

Sharing My RMS Journey to Inspire Others

No one should feel like they are going through their relapsing MS journey alone. The Reflect, Reframe, Reach Out Guide is inspired by my experiences. It's designed to help you define your needs, have honest conversations with your care team, and help you own your RMS story.

Hear other stories like Jamie-Lynn’s from the KESIMPTA Crew

Watch how to take KESIMPTA, step-by-step

Sign Up Icon

Want more information to help you decide?

Find out why so many people are choosing KESIMPTA.

Phone Headset Icon

Want co-pay help?

97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card‡§ from the Alongside™ KESIMPTA Patient Support Program.

Jamie-Lynn S. has taken KESIMPTA and has been compensated for her time.
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.
*In 2 studies vs teriflunomide.
Once monthly after 3 weekly starter doses.
Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
§2023 data on file.

KESIMPTA, the KESIMPTA logo, and SENSOREADY are registered trademarks of Novartis AG.
ALONGSIDE and the ALONGSIDE logo are trademarks of Novartis AG. 
AUBAGIO is a registered trademark of Genzyme, a Sanofi company. 
Please see each product’s respective PI for additional information including indication, dosing, and safety.